Coronavirus Update: WHO director-general calls for moratorium on booster shots
- ByMarketWatch-
Coronavirus Update: WHO director-general calls for moratorium on booster shots
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AstraZeneca PLC (AZNCF)
Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| London | GBP | Real-time | ||
| Derived | GBP | Real-time | ||
| London | GBP | Real-time | ||
| London | GBP | Real-time | ||
| BATS Europe | SEK | Delayed | ||
| BATS Europe | GBP | Delayed | ||
| OTC Markets | USD | Delayed | ||
| NASDAQ | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| Buenos Aires | ARS | Delayed |
116.560
+1.072(+0.93%)
After Hours
114.500
-2.060(-1.767%)
- Delayed Data
- Volume:1,271
- Bid/Ask:0.000/0.000
- Day's Range:116.560 - 120.300
AZNCF Overview
- Prev. Close
- 115.488
- Day's Range
- 116.56-120.3
- Revenue
- -
- Open
- 120.3
- 52 wk Range
- 93.13-124.95
- EPS
- -
- Volume
- 1,271
- Market Cap
- 177.95B
- Dividend (Yield)
- N/A(N/A)
- Average Volume (3m)
- 2,736
- P/E Ratio
- -
- Beta
- -
- 1-Year Change
- 3.02%
- Shares Outstanding
- 1,549,116,349
- Next Earnings Date
- 12 Nov 2021
What is your sentiment on AstraZeneca PLC?
or
Market is currently closed. Voting is open during market hours.
AstraZeneca PLC News
- Coronavirus Update: Delta variant is now in 135 countries, says WHO, as its head calls for moratorium on boosters to allow poorer countries get first doses
- ByMarketWatch-
The highly transmissible delta variant of the coronavirus that causes COVID-19 is now in 135 countries, the World Health Organization said Wednesday, as its head called for a...
AstraZeneca PLC Analysis
- AstraZeneca PLC 2021 Q2 - Results - Earnings Call Presentation
- BySeeking Alpha-
- Stocks Reverse Gains as Inflation Fears Weigh
- ByTalkmarkets-
Stocks reversed earlier gains brought on by strong retail sales data and mixed earnings reports, as worse-than-expected inflation findings weighed on Wall Street.
- AstraZeneca, J&J Working On 'Modifications' To Eliminate Potentially Deadly Side Effects
- ByZeroHdge-
AstraZeneca, J&J Working On 'Modifications' To Eliminate Potentially Deadly Side EffectsYesterday, the FDA confirmed that the Johnson & Johnson jab may be linked to rare side...
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Buy | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Buy |
| Summary | Neutral | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,679.00 | 2,714.50 | 2,679.00 | -27.0 | -1.00% | 1.93M | London | |||
| 174.25 | 175.60 | 172.40 | -0.60 | -0.34% | 11.87M | London | |||
| 165.75 | 167.30 | 164.30 | +0.15 | +0.09% | 6.71M | London | |||
| 164.00 | 164.00 | 164.00 | 0.00 | 0.00% | 1.00K | London | |||
| 114.30 | 114.55 | 112.35 | +1.80 | +1.60% | 11.97M | London | |||
| 7.80 | 8.20 | 7.80 | +0.25 | +3.33% | 5.45M | London | |||
| 82.75 | 84.15 | 82.10 | +0.50 | +0.61% | 2.35M | London | |||
| 1,433.60 | 1,441.20 | 1,430.20 | +0.20 | +0.01% | 4.46M | London | |||
| 47.59 | 47.60 | 46.39 | +0.47 | +1.00% | 15.88M | London | |||
| 6,292.00 | 6,342.00 | 6,259.00 | +11.0 | +0.17% | 2.53M | London | |||
| 170.58 | 174.68 | 169.32 | -0.32 | -0.19% | 15.16M | London | |||
| 246.00 | 249.50 | 245.00 | -4.00 | -1.60% | 256.75K | London | |||
| 303.00 | 310.60 | 299.20 | -3.10 | -1.01% | 68.03M | London | |||
| 1,561.00 | 1,583.00 | 1,561.00 | -15.50 | -0.98% | 2.44M | London | |||
| 255.60 | 259.60 | 255.40 | -1.40 | -0.55% | 528.92K | London |
AstraZeneca PLC Company Profile
AstraZeneca PLC Company Profile
AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company’s marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; AliveCor, Inc. to develop non-invasive potassium monitoring solutions; Massachusetts General Hospital to accelerate digital health solutions; Sanguina on smartphone application study for hemoglobin management in patients with anemia of chronic kidney disease; Alchemab to enhance prostate cancer research; and Proteros biostructures GmbH to discover and develop novel small molecules for the treatment of various types of cancer. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Read More
- 2021-06-24 12:33:28good investment
- 2021-06-16 13:57:45
Looks like it will be flying soon.... - 2021-06-04 14:55:02how do u start trading?
- 2021-06-12 22:32:27Help
- 2021-07-07 07:18:21Buy shares - sell them. Hopefully at a profit. Where - a trading platform. Requirements - ID and money.
- 2021-05-15 23:49:26do I invest please help
- 2021-05-03 07:43:01This stock is more unpredictable than the roulette tables
- 2021-04-22 20:42:05net short positions available on the PNC Borsa app
- 2021-04-19 11:11:36damn
- 2021-04-14 19:29:33Now is the time to go short.
- 2021-04-14 19:29:13Now is the time to go short.
- 2021-04-13 17:52:06love it
- 2021-04-11 22:17:24
6000 is coming, time to short - 2021-03-24 16:53:29is night mare
- 2021-03-30 20:01:24This stock is Toxic.
- 2021-03-22 17:28:18What a crock- the vaccine is being done at cost
- 2021-03-25 02:17:57
Maybe so, but there other products aren't, and it reflects on them too.
- 2021-03-22 16:55:25Here We Go
- 2021-03-18 17:38:06On bad news this rallied 3.5%. Today on good news it declines.
- 2021-03-16 10:17:15they are only giving it at profit as long as it is declared a pandemic. After that will probably need annual jabs. Weird it has gone up - they must be expecting it to be declared ok and lets Astra off hook for the shortfalls to EU at moment. Looks like EU might have shot itself in foot, moaning about shortfalls then stopping it. Perhaps EU wanted to get its money back by saying it doesn't work. Who knows.
- 2021-03-16 14:43:32I think both parties have break clauses in the contract. Defo politics at play with this 🤪
- 2021-03-19 07:24:25Simon Morrisnot suprising though, hard not to be with the games the bloc is playing.
- 2021-03-22 08:05:48US study will put that bang to rights 🤷🏼♂️🤪
- 2021-03-16 09:37:50
Why has this jumped on bad Vaccine News, I know they are doing it for cost but price jump don't make sense, just trying to learn.- 2021-03-16 09:52:56Despite of bad news share price is not going down. Today european medical council has to review. And now short selling is squeezed
- 2021-03-16 14:41:44Canada are about to approve it for over 65’s and US are not far behind them. Unlike a few other nations they are following the science.🤪
- 2021-03-16 09:03:14This is the time short seller are squeezed
- 2021-03-15 09:20:30I thought it would completely collapse like 10%. But looking at the chart and PE, this has already pulled back to before covid.Show previous replies (1)
- 2021-03-15 16:24:40Unlikely as the data doesn’t supoort the coutries citing thrombrosis issues as the numbers are far less than occur normally in the community. Its just everything is being blamed on vaccines....next we will see is a flat tyre being blamed on vaccine 🤪
- 2021-03-15 16:44:56Simon Morris It's true, I had a flat tyre and I found out that it was the vaccine. So until I see proof that it wasn't the vaccine I am going to ride around on steel rims/hubs. It has got to be better than using that horrible old vaccine. Europeans eh? Cant live with them can live without them. I can say that because my wife is Italian :) Actually let me just go and check that with her.
- 2021-03-15 17:42:08Peter kurbe nice to your good lady or she might cut off the chianti 👀🤭😆
- 2021-03-15 08:50:536000 is coming, time to short
- 2021-03-15 14:11:13It's become gambling at this moment to try and predict the price movement. It is true that there are some apparent issues with their vaccines, but I expect them to sort it all out in a matter of weeks. Also, it is not like people are massively dying because of their vaccine - that would be really troublesome and would most certainly cause a bigger price collapse.
- 2021-03-15 08:22:17This will go down more, Issues with Astrazenica Oxford Vaccines.
- 2021-03-15 16:26:22There are no issues or we’d see numbers far in excess of the normal levels in the community. If anything the cases of clots are a lot less than occur normally 🤷🏼♂️
- 2021-03-08 12:34:47Is Azn worth buying at this price or is there going to be a further drop?
- 2021-03-04 11:38:5103/03/21 Astrazeneca: Deutsche Bank reiterates buy with a target price of 10,000p.
- 2021-03-03 15:05:45Is it still worth keeping AZN, when is the divident and how much it would be
- 2021-02-25 12:20:45As I said in Jan this will touch 7000 and here we are. If it goes below then 6700 is the next stop
- 2021-03-01 11:16:046700 is coming very soon
- 2021-03-02 08:23:55
thanks what the reason for weakness ?
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.